Added value of using gene expression signature test Mammaprint for adjuvant chemotherapy decision-making in early breast cancer

Added value of using gene expression signature test Mammaprint for adjuvant chemotherapy decision-making in early breast cancer
Country
Agency
Year work was carried out
Link
Details of use
Austria
LBI-HTA
http://eprints.hta.lbg.ac.at/1147/1/HTA-Projektbericht_Nr.102.pdf
Dissemination to decision makers.
Austria
GOEG
2018
National adaptation. Made no changes to the EUnetHTA report, added a German summary.
Belgium
KCE
2018
https://kce.fgov.be/en/mammaprint®-test-for-personalised-management-of-adjuvant-chemotherapy-decisions-in-early-breast
National adaptation. Added local information.
Croatia
AAZ
Ongoing
Dissemination – prepared the Summary and assessment elements B0001 and A0020 in Croatian (will be published on the AAZ website along with links to the full EUnetHTA assessment).
France
HAS
2019
https://www.has-sante.fr/portail/jcms/c_2748998/fr/utilite-clinique-des-signatures-genomiques-dans-le-cancer-du-sein-de-stade-precoce-rapport-d-evaluation
National adaptation. Added local information.
Italy
ASSR RER
Ongoing
Dissemination of the EUnetHTA report will be carried out through our website: news of publication and link; summary and results provided.
Italy
AGENAS
2018
National adaptation. Added local information.
Netherlands
ZIN
Ongoing
National adaptation. Added local information.
Norway
NIPHNO
Ongoing
National adaptation.
Slovakia
UNIBA
2018
National adaptation. Added local information.
Spain
OSTEBA
2018
The OTCA04 assessment was disseminated among the coordinators of the Breast Cancer Screening Program, among gynaecologists and among relevant decision makers.
Spain
AQUAS
Ongoing
The OTCA04 assessment will be disseminated to Catalan regional decision makers (physicians societies, director of corresponding plan, and Health Services Planners).
UK
NICE
2018
https://www.evidence.nhs.uk/search?q=EUnetHTA
This was originally assessed in DG10 https://www.nice.org.uk/guidance/dg10 It is currently being updated as part of guidance on a broader topic area. The HTA to inform the update was published before the EUnetHTA assessment was available. EUnetHTA reports are indexed in NHS evidence a database managed by NICE that supports evidence.